Vimarsana
Biggest News Aggregation in the World

Page 6 - Pulse Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pulse Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pulse Bioscience Today - Breaking & Trending Today

Pulse Biosciences Announces the Appointment of Kevin Danahy as Chief Commercial Officer - Vimarsana News

Pulse Biosciences Announces the Appointment of Kevin Danahy as Chief Commercial Officer

Pulse Biosciences Announces the Appointment of Kevin Danahy as Chief Commercial Officer - read this article along with other careers information, tips and advice on BioSpace

Pulse Biosciences, Inc.: Pulse Biosciences Announces First CellFX Procedures Performed in Europe as Part of Global Controlled Launch - Vimarsana News

Pulse Biosciences, Inc.: Pulse Biosciences Announces First CellFX Procedures Performed in Europe as Part of Global Controlled Launch

(2) Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation (NPS) technology, today announced that the first CellFX procedures in the European Union were successfully completed. The initial commercial use of the non-thermal, cellular-focused CellFX System to clear common benign lesions, now expands the Company's controlled launch program starting with the top aesthetic dermatologists and plastic surgeons across Europe. This strategic rollout in Europe will run in parallel with the Company's U.S. controlled launch aimed at building a stro...

Pulse Biosciences Announces First CellFX Procedures Performed in Europe as Part of Global Controlled Launch - Vimarsana News

Pulse Biosciences Announces First CellFX Procedures Performed in Europe as Part of Global Controlled Launch

Press release content from Business Wire. The AP news staff was not involved in its creation. Pulse Biosciences Announces First CellFX Procedures Performed in Europe as Part of Global Controlled Launch February 19, 2021 GMT HAYWARD, Calif.--(BUSINESS WIRE)--Feb 19, 2021-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS™) technology, today announced that the first CellFX ® procedures in the European Union were successfully completed. The initial commercial use of the non-thermal, cellular-focused CellFX System to clear ...

Source: apnews.com
Pulse Biosciences Announces Start of Controlled Launch of the CellFX System® - Vimarsana News

Pulse Biosciences Announces Start of Controlled Launch of the CellFX System®

Published: Feb 16, 2021 Pulse Biosciences Announces Start of Controlled Launch of the CellFX System ® - First Aesthetic Dermatology Patients Treated in the U.S.   HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS™) technology, today announced that the first clinic patients have been treated with the CellFX ® System. This first commercial use of the CellFX System marks the initiation of the Company’s controlled launch program with product shipments to respected leaders in dermato...